re: Ann: Cellestis Limited Announces Improved... Cellestis has always marketed the QFT as a test for latent TB. Any recommendation by the WHO against using IGRA tests for active TB will have no impact on Cellestis or the growth in sales for our latent TB test.
In short, it is not a good reason to consider selling our share in the company to Qiagen for such a low price.
- Forums
- ASX - By Stock
- Ann: Cellestis Limited Announces Improved Proposa
re: Ann: Cellestis Limited Announces Improved... Cellestis has...
Featured News
Add CST (ASX) to my watchlist